RB-E2F system in the progression and evolution of squamous cell carcinoma of the uterine cervix
RB-E2F system in the progression and evolution of squamous cell carcinoma of the uterine cervix
批准号:
08670197
负责人:
NAKANISHI Isao
金额:
$1.22万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1996
资助国家:
日本
项目状态:
已结题
起止时间:
1996 至 1997
中文摘要
与细胞增殖调控机制有关的RB-E2F系统的改变被认为参与了人类鳞状细胞癌(SCC)的发生演变。在本研究中,我们检测了24例宫颈鳞状细胞癌RB蛋白的异常表达,以及HPV-16或HPV-18的E6和E7基因的参与。采用定量RT-PCR方法比较11例肺鳞癌组织与正常肺组织中E2F-1 mRNA的表达。HPV 16-E6和E7基因的检出率分别为87.5%和71.4%。免疫组化检测RB蛋白阳性率分别为80.9%和86.6%。与HPV-16相比,HPV-18的检测水平较低。检测E2F-1 mRNA, SCC组织中总mRNA为5.3(]SY.+- . [)3.8fg/ng,总mRNA为1.2(]SY.+- . [)0.5fg/ng,提示E2F系统异常过度表达。RB蛋白在正常组织中呈阴性,在SCC组织中呈持续阳性。推测RB蛋白积累-E2F的过度表达与人宫颈及肺源性鳞状细胞癌的发生发展密切相关。
英文摘要
The alteration of RB-E2F system which is concerned with regulatory mechanism of cell proliferation is supposed to be involved in the progression and evolution of human squamous cell carcinoma (SCC). In the present study, we examined the abnormal expression of RB protein, and the involvement of E6 and E7 genes of HPV-16 or HPV-18 in 24 cases of SCC of the uterine cervix. In addition, E2F-1 mRNA was comparatively measured in 11cases of lung SCC tissue and normal lung tissue by quantitative RT-PCR.HPV 16-E6 and E7 genes were identified 87.5% and 71.4% respectively. RB protein was positively detected at 80.9% and 86.6% by immunohsitochemistry. HPV-18 was detected at the low level as compared with HPV-16. E2F-1 mRNA was measured, showing 5.3(]SY.+-。[)3.8fg/ng total mRNA in SCC tissue and 1.2(]SY.+-。[)0.5fg/ng total mRNA,suggestive of abnormal excessive expression of E2F system. RB protein was negative in normal tissue and constantly positive in SCC tissue. It is presumed that RB protein accumulation -E2F excessive expression would be strongly related to the development of human squamous cell carcinoma derived from the uterine cervix as well as the lung.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Person Authentication System Using Intra-Palm Propagation Signal
-
批准号:22560377
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.5万
-
财政年份:2010
-
负责人:NAKANISHI Isao
-
依托单位:
Development of a method to discover high affinity ligands using molecular dynamics simulation
-
批准号:22590110
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2010
-
负责人:NAKANISHI Isao
-
依托单位:
Development of the prediction method of ligand binding affinity in SBDD
-
批准号:18590096
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.27万
-
财政年份:2006
-
负责人:NAKANISHI Isao
-
依托单位:
Development of Multi-Modal Biometric Authentication Chip toward Ubiquitous Network Society
-
批准号:17560340
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.33万
-
财政年份:2005
-
负责人:NAKANISHI Isao
-
依托单位:
Development of Wavelet Domain Multi-Dimensional Adaptive Filter and Its Application to On-line Signature Verification
-
批准号:12650382
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.22万
-
财政年份:2000
-
负责人:NAKANISHI Isao
-
依托单位:
Expression and distribution of UV-DDB in the nerve cells and tissues
-
批准号:11670209
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.11万
-
财政年份:1999
-
负责人:NAKANISHI Isao
-
依托单位:
国内基金
海外基金
登录
查看更多内容
HPV检测数据智能分析系统开发
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:李灿
-
依托单位:
CCDC3介导TWEAK/Fn14信号调控HPV感染细胞增殖与疣体复发的机制研究
-
批准号:JCZRLH202601521
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
METTL3介导HPV16 E6的转录后修饰参与宫颈病变演进的机制研究
-
批准号:2026JJ50335
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:杨文青
-
依托单位:
HPV相关阴茎鳞状细胞癌Ly6G+GBP5hi巨噬细胞通过炎性外泌体介导免疫抑制微环境的作用和机制研究
-
批准号:2026JJ80914
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:郭洁
-
依托单位:
新型溶瘤性HPV治疗性疫苗MATV003的构建和药效学研究
-
批准号:JCZRMS202601746
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
阴道微生态代谢失衡驱动HPV持续感染诱发宫颈病变的免疫机制研究
-
批准号:2026JJ82505
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:陈智慧
-
依托单位:
HPV通过C/EBPβ/miR-31/FAT4轴调控宫颈癌发生的机制研究
-
批准号:2026JJ80038
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:刘伟
-
依托单位:
阴道毛滴虫tsRNA通过“DNA损伤-免疫抑制”双刃剑模式协同HPV驱动宫颈癌前病变的机制研究
-
批准号:JCZRLH202602136
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
HPV16E6/E7蛋白通过RNA甲基化修饰介导宫颈癌组织中ATAD2过度表达的机制研究
-
批准号:2026JJ82547
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:陈炜
-
依托单位:
HPV介导PAX1甲基化调控IFI27/JAK/STAT通路增加宫颈癌放疗敏感性的机制研究
-
批准号:2026JJ81352
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:朱红
-
依托单位: